Dr. Jeff Gudin discusses whether patients can build a tolerance to opioid-induced constipation.

In this video, Dr. Chris Herndon discusses the risk factors for developing opioid-induced constipation.

Dr. Jeff Gudin discusses the newer agents available for opioid-induced constipation and the possible adverse effects these medications can cause.

In this video, Dr. Jeff Gudin discusses current standards of care in opioid-induced constipation.

Dr. Chris Herndon discusses how to assess for opioid-induced constipation.

In this video, Dr. John Coleman discusses what he believes to be the driver behind the resurgence of heroin use in the United States.

In this video, Dr. Kathryn Hahn discusses whether the genetic makeup of an individual influences the patient's vulnerability to an opioid use disorder.

In this video, Dr. Kathryn Hahn discusses whether prescription drug monitoring programs can be accessed across states.

In this video, Dr. Kenneth Kirsh discusses the four domains to consider for assessing pain outcomes.

In this video, Dr. Kathryn Hahn discusses whether all prescription drug monitoring programs are operationally the same.